EFFICACY OF TOFACITINIB BY BACKGROUND METHOTREXATE DOSE IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST-HOC ANALYSIS OF POOLED DATA FROM 2 PHASE 3 TRIALS

被引：1
|
作者：
Kivitz, A. J. [1 ]
FitzGerald, O. [2 ]
Nash, P. [3 ]
Pang, S. [4 ]
Azevedo, V. F. [5 ]
Kudlacz, E. [6 ]
Wang, C. [6 ]
Graham, D. [6 ]
Takiya, L. [7 ]
机构：
[1] Altoona Ctr Clin Res, Dept Rheumatol, Duncansville, PA USA
[2] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
[3] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[4] St Jude Med Ctr, Fullerton, CA USA
[5] Univ Fed Parana, Curitiba, Parana, Brazil
[6] Pfizer Inc, Groton, CT 06340 USA
[7] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.1278
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0902
引用
收藏
页码：1575 / 1575
页数：1
相关论文
共 50 条
  • [1] Efficacy of Tofacitinib By Background Methotrexate Dose in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Pooled Data from 2 Phase 3 Trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Kudlacz, Elizabeth
    Wang, Cunshan
    Graham, Daniela
    Takiya, Liza
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Wang, Cunshan
    Takiya, Liza
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (02) : 499 - 511
  • [3] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Alan J. Kivitz
    Oliver FitzGerald
    Peter Nash
    Shirley Pang
    Valderilio F. Azevedo
    Cunshan Wang
    Liza Takiya
    [J]. Clinical Rheumatology, 2022, 41 : 499 - 511
  • [4] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF PHASE 3 STUDIES
    Ritchlin, C.
    Giles, J.
    Ogdie, A.
    Gomez-Reino, J.
    Stockert, L.
    Young, P.
    Wang, C.
    Romero, A. B.
    Kudlacz, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1023 - 1023
  • [5] Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Yamaoka, Kunihiro
    Arai, Shoko
    Toyoizumi, Shigeyuki
    DeMasi, Ryan
    Fukuma, Yuri
    Hirose, Tomohiro
    Sugiyama, Naonobu
    Zwillich, Samuel H.
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2019, 29 (05) : 756 - 766
  • [6] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    [J]. RMD OPEN, 2023, 9 (01):
  • [7] Anamorelin in Cachectic Patients with Advanced NSCLC, a Post-Hoc Pooled Efficacy Data Analysis of Two Phase 3 Trials
    Currow, David
    Teme, Jennifer
    Abernethy, Amy
    Friend, John
    Fearons, Kenneth
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S665 - S666
  • [8] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Philip J. Mease
    Ana-Maria Orbai
    Oliver FitzGerald
    Mohamed Bedaiwi
    Rajiv Dona L. Fleishaker
    Pamela Mundayat
    Philip S. Young
    [J]. Arthritis Research & Therapy, 25
  • [9] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Mease, Philip J.
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela S.
    Helliwell, Philip
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [10] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
12345